Recent Finacing
Recent Raise
Histide AG develops an extracellular, non‑mutagenic platform of Recoding Molecules and engineered microenvironments that steer cell differentiation without foreign genetic material, managing IP, academic partnerships, and clinical licensing programs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor